XenoTherapeutics

XenoTherapeutics

Biotechnology Research 359 Newbury Street 13 employees
Employees
13
Contacts
4
Emails
4
Phones
2

XenoTherapeutics Overview

Headquarters
359 Newbury Street
Industry
Biotechnology Research
Employees
13
Founded
2016
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About XenoTherapeutics

XenoTherapeutics is a not-for-profit, clinical-stage regenerative medicine company developing innovative cell and tissue-based research solutions. Our FDA-accepted pathogen screening and validated assays provide a robust regulatory pathway for the clinical advancement of xenogeneic cells, tissues, and organs. We accelerate the development, testing, training, and commercialization of innovative, live biotherapeutic products that deliver on the promise of regenerative medicine.

XenoTherapeutics Contact Details

People in AeroLeads
4
With contact data
4
Email contacts
4
100.0% coverage
Phone contacts
2
50.0% coverage

XenoTherapeutics Org Chart

Sample employees and titles
Name Title Contact
Jon Adkins President & Co-founder, Xenotherapeutics - Advancing Human Therapy — from Pigs to Patients
Email
Ruta Laukien Strategic Capital Advisor - Partnering with Companies to Scale, Grow, and Lead
Email Phone
Robert Kaiser, Phd, Dabt Toxicologist Entrepreneur
Email
Mark Nedelman Founder, President & CEO, Anewcro Llc.
Email Phone

Employees by Management Level

Executive 3 profiles
Individual contributor 3 profiles
Senior / Lead 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 1 1 0

Compare Similar Companies to XenoTherapeutics